HK1021698A1 - Room temperature storable immunoglobulin preparation for intravenous injection. - Google Patents

Room temperature storable immunoglobulin preparation for intravenous injection.

Info

Publication number
HK1021698A1
HK1021698A1 HK00100597A HK00100597A HK1021698A1 HK 1021698 A1 HK1021698 A1 HK 1021698A1 HK 00100597 A HK00100597 A HK 00100597A HK 00100597 A HK00100597 A HK 00100597A HK 1021698 A1 HK1021698 A1 HK 1021698A1
Authority
HK
Hong Kong
Prior art keywords
intravenous injection
room temperature
immunoglobulin preparation
temperature storable
immunoglobulin
Prior art date
Application number
HK00100597A
Other languages
English (en)
Inventor
Yutaka Hirao
Motonori Hashimoto
Tae Kitamura
Yahiro Uemura
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17768099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1021698(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of HK1021698A1 publication Critical patent/HK1021698A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
HK00100597A 1997-10-23 2000-01-31 Room temperature storable immunoglobulin preparation for intravenous injection. HK1021698A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29137497 1997-10-23

Publications (1)

Publication Number Publication Date
HK1021698A1 true HK1021698A1 (en) 2000-06-30

Family

ID=17768099

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00100597A HK1021698A1 (en) 1997-10-23 2000-01-31 Room temperature storable immunoglobulin preparation for intravenous injection.

Country Status (11)

Country Link
US (2) US6159471A (de)
EP (1) EP0911037B2 (de)
KR (1) KR100632312B1 (de)
CN (2) CN1149100C (de)
AT (1) ATE224203T1 (de)
CA (1) CA2251342A1 (de)
DE (1) DE69808012T3 (de)
DK (1) DK0911037T3 (de)
ES (1) ES2182202T5 (de)
HK (1) HK1021698A1 (de)
PT (1) PT911037E (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4685238B2 (ja) 1998-06-09 2011-05-18 ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
US20040156835A1 (en) * 2001-05-30 2004-08-12 Taiji Imoto Protein preparation
TW200300173A (en) * 2001-11-13 2003-05-16 Nisshin Oillio Ltd Process for producing concentrated/purified protein using clay mineral composition
KR101080021B1 (ko) 2002-02-14 2011-11-04 추가이 세이야쿠 가부시키가이샤 항체함유 용액제제
US20040033228A1 (en) * 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) * 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
FR2854801B1 (fr) * 2003-05-12 2006-09-01 Khorionyx Implant injectable de globine insoluble
EP1532983A1 (de) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulinpräparationen mit erhöhter Stabilität
US7723306B2 (en) 2004-05-10 2010-05-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation
DE102004022927A1 (de) * 2004-05-10 2005-12-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg 1,4 O-verknüpfte Saccharose-Derivate zur Stabilisierung von Antikörpern oder Antikörper-Derivaten
US7727962B2 (en) 2004-05-10 2010-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder comprising new compositions of oligosaccharides and methods for their preparation
US7611709B2 (en) 2004-05-10 2009-11-03 Boehringer Ingelheim Pharma Gmbh And Co. Kg 1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives
CN101478945B (zh) * 2006-06-28 2013-07-31 藤森工业株式会社 液体收纳容器
WO2008100578A2 (en) * 2007-02-14 2008-08-21 Amgen Inc. Method of isolating antibodies by precipitation
NZ580379A (en) 2007-03-29 2012-10-26 Abbott Lab Crystalline anti-human il-12 antibodies
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
ES2716088T3 (es) 2010-02-04 2019-06-10 Csl Behring Ag Preparado de inmunoglobulina
EP2361636A1 (de) 2010-02-26 2011-08-31 CSL Behring AG Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
MX344727B (es) 2010-11-11 2017-01-05 Abbvie Biotechnology Ltd Formulaciones liquidas de anticuerpos anti-tnf-alfa de alta concentracion mejoradas.
CN103608352A (zh) 2011-06-24 2014-02-26 旭化成医疗株式会社 蛋白制剂的制造方法
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
CN103341187B (zh) * 2012-06-28 2016-06-22 四川远大蜀阳药业股份有限公司 一种终端灭活病原微生物的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378346A (en) * 1979-08-15 1983-03-29 Tankersley Donald L Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
FR2582515B1 (fr) * 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
JP2547556B2 (ja) † 1987-02-06 1996-10-23 株式会社 ミドリ十字 ｒ−グロブリンの液状製剤
JP2613409B2 (ja) * 1987-11-20 1997-05-28 株式会社ミドリ十字 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
DE4125625C2 (de) † 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
JPH0761935A (ja) * 1993-08-25 1995-03-07 Green Cross Corp:The 静注用免疫グロブリン製剤の製造方法
JP4003235B2 (ja) * 1994-09-30 2007-11-07 三菱ウェルファーマ株式会社 静注用免疫グロブリン製剤の製造方法
ATE211486T1 (de) * 1995-09-22 2002-01-15 Zlb Bioplasma Ag Verfahren zur gewinnung von immunglobulinen aus fraktionen, die bei der fraktionierung von menschlichem blutplasma entstehen
CA2232420A1 (en) * 1997-03-19 1998-09-19 The Green Cross Corporation Immunoglobulin preparation and preparation process thereof

Also Published As

Publication number Publication date
US6159471A (en) 2000-12-12
CN1149100C (zh) 2004-05-12
PT911037E (pt) 2002-12-31
ATE224203T1 (de) 2002-10-15
US6485725B1 (en) 2002-11-26
DK0911037T3 (da) 2002-12-02
DE69808012T3 (de) 2008-01-24
EP0911037B1 (de) 2002-09-18
KR100632312B1 (ko) 2007-05-14
CN1520885A (zh) 2004-08-18
CA2251342A1 (en) 1999-04-23
DE69808012D1 (de) 2002-10-24
ES2182202T3 (es) 2003-03-01
DE69808012T2 (de) 2003-08-14
CN1224620A (zh) 1999-08-04
EP0911037A1 (de) 1999-04-28
EP0911037B2 (de) 2007-06-13
ES2182202T5 (es) 2007-12-01
KR19990037317A (ko) 1999-05-25

Similar Documents

Publication Publication Date Title
HK1021698A1 (en) Room temperature storable immunoglobulin preparation for intravenous injection.
EP1408108A3 (de) Cellulase aus Actinomycetes und Herstellungverfahren
WO1999025847A3 (en) Cellulase produced by actinomycetes and method of producing same
DE69829308D1 (de) Cellulase aus actinomycetes und herstellungsverfahren dafür
FR2690920B1 (fr) Dérivés 1-hydrocarbyloxy-2,2,6,6-tétraméthylpipéridiniques de 1,3,5-triazines non-migrants comme stabilisants de matières polymères.
EP0850653A3 (de) Katheterübergangssystem
EP0657497A4 (de) Thermoplastische harzzusammensetzung und verfahren zum formen derselben.
EP1277792A3 (de) Biologisch abbaubare Plastikzusammensetzung und Methode zur Kontrolle ihrer biologischen Abbaurate
AU3804295A (en) Increasing the molecular weight of polycondensates
AU1520895A (en) Purified primate ctla-8 antigens and related reagents
AU8070494A (en) Latent, thermal cure accelerators for epoxy-aromatic amine resins
WO1997013749A3 (en) Novel cinnamamides and their use as stabilizers
EP0742244A3 (de) Härtbare Polysulfidpolymerzusammensetzung für optisches Material
AU4015693A (en) Polysuccinimide polymers and process for preparing polysuccinimide polymers
DK0530447T3 (da) Fremgangsmåde til rensning af IgG-monoklonale antistoffer
HUT69796A (en) Vaccine against streptococcus suis infection
DE3176529D1 (en) Radiation cross-linking of polyamides
ES8304431A1 (es) "un metodo para preparar una inmunoglobulina adecuada para administracion intravenosa".
DK0676965T3 (da) Fremgangsmåde til at reducere immunogeniciteten af variable regioner på antistoffer
WO1994025527A3 (en) Improved bonding resin and methods relating thereto
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0389640A4 (en) Resin composition having excellent heat stability and weatherability
DE3173666D1 (en) Process for preparing immunoglobulin suitable for intravenous injection
SE9201731L (sv) Härdare innehållande alkylaminsalter förlimning med aminobaserade lim av träbaserade podukter
EP0654341A3 (de)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081023